Ergebnis der Suchanfrage nach M&uuml

Inhalte

Filtern
2632 Treffer
  • 06.11.2006 – 08:32

    Nordex SE

    Nordex awarded contracts worth over EUR 69 million in France

    28 turbines with an output of approx. 70 MW to be constructed in seven wind farms ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Hamburg, November 6, 2006 - Nordex AG has been awarded three project contracts for the turnkey construction of seven wind farms comprising a total of 28 N90 turbines in France. The combined value of the contracts for Nordex ...

  • 02.11.2006 – 23:26

    Qualcomm Incorporated

    QUALCOMM Announces Fourth Quarter and Fiscal 2006 Results

    San Diego, November 2 (ots/PRNewswire) - Fiscal 2006 Revenues US$7.53 Billion, EPS US$1.44 Pro Forma Fiscal 2006 Revenues US$7.53 Billion, EPS US$1.64 Record Fiscal Year Revenues, Net Income and Operating Cash Flows QUALCOMM Incorporated (Nasdaq: QCOM) today announced results for the fourth fiscal quarter and fiscal 2006 year ended September 24, 2006. Total QUALCOMM (GAAP) ...

  • 31.10.2006 – 08:03

    Shire Pharmaceuticals Group Plc

    Shire Launches New Trial for First Renal Anaemia Treatment Produced in Human Cell Lines

    Basingstoke, England (ots/PRNewswire) - Shire today announced the start of a new Phase IIIb clinical trial to evaluate two new dosing schedules of DYNEPO(R) (epoetin delta), the first commercial erythropoiesis-stimulating agent produced in a human cell line. DYNEPO is used in the treatment of anaemia in patients with chronic kidney disease (CKD[i]). Anaemia becomes ...

  • 26.10.2006 – 08:24

    Gemalto

    Gemalto Reports Third Quarter 2006 Revenue[1]

    Amsterdam (ots/PRNewswire) - - Third Quarter Revenue at EUR 390 Million, Down 8% at Constant Exchange Rates, as Market Environment Remains Difficult in Mobile Communication - Year-to-date Pro Forma Revenue at EUR1,237 Million, 1% Lower Than Last Year at Constant Exchange Rates, and Stable at Current Exchange Rates - Deployments of Electronic Passports Projects Lead to 20% Growth in ID & Security in the ...

  • 25.10.2006 – 13:56

    Dewey Ballantine LLP; LeBoeuf Lamb

    Dewey and Orrick Reach Major Milestone in Merger Discussions

    New York (ots/PRNewswire) - Dewey Ballantine LLP and Orrick, Herrington & Sutcliffe LLP, two leading global law firms, announced today that the firms' respective Management and Executive Committees have made initial recommendations to their partners about combining into a new firm named Dewey Orrick LLP that will retain Orrick's well-known "O" brand. Ralph Baxter, Orrick's current Chairman, and Morton A. Pierce, ...

  • 18.09.2006 – 09:05

    Nordex SE

    Nordex awarded further major contract in Italy

    Contract worth EUR 47 million for wind farm in Sicily ots-CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Hamburg, September 18, 2006. Nordex AG has been awarded a contract for the construction of the Vicari wind farm. In the initial construction phase, the wind farm will comprise 15 N90/2500 turbines. The project is worth around EUR 47 million. In addition ...

  • 16.09.2006 – 13:46

    Eli Lilly and Company

    New Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Insulin Glargine

    Copenhagen, Denmark (ots/PRNewswire) - - Patients Taking Exenatide Lost Weight While Patients Taking Insulin Glargine Gained Weight Eli Lilly and Company (NYSE: LLY) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced results from a study indicating that exenatide improves blood sugar levels as effectively as insulin glargine (Lantus(R), Sanofi ...

  • 14.09.2006 – 11:04

    Eli Lilly and Company

    Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart

    Copenhagen, Denmark (ots/PRNewswire) - - Patients on exenatide lost weight, while insulin aspart patients gained weight - Eli Lilly and Company (NYSE: LLY) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced results from a study indicating that exenatide improves blood sugar levels as effectively as biphasic insulin aspart 30/70 (NovoMix 30(R), ...

  • 13.09.2006 – 12:22

    Gemalto

    Gemalto First Half 2006 Results

    Amsterdam (ots/PRNewswire) - - Revenue[1] Up 2% at Constant Exchange Rates (-1% at Current Exchange Rates) - Operating Margin1 at 3.7%, Reflecting Fierce Competition in Mobile Communication - Cash and Cash Equivalents at USD 478 Million - Continuing Challenging Industry Environment - Synergies and Long-Term Objectives Confirmed Gemalto (Euronext NL0000400653 - GTO), a leader in digital security, today announced its results for the half year ended ...